000			02190 a2200601 4500
005			20250516021126.0
264		0	_c20110512
008			201105s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/j.1365-2141.2010.08317.x _2doi
040			_aNLM _beng _cNLM
100	1		_aHillmen, Peter
245	0	0	_aA randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. _h[electronic resource]
260			_bBritish journal of haematology _cMar 2011
300			_a570-8 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aNeoplasm, Residual
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aVidarabine _xadministration & dosage
700	1		_aCohen, Dena R
700	1		_aCocks, Kim
700	1		_aPettitt, Andrew
700	1		_aSayala, Hazem A
700	1		_aRawstron, Andy C
700	1		_aKennedy, Daniel B
700	1		_aFegan, Christopher
700	1		_aMilligan, Don W
700	1		_aRadford, John
700	1		_aMercieca, Jane
700	1		_aDearden, Claire
700	1		_aEzekwisili, Raphael
700	1		_aSmith, Alexandra F
700	1		_aBrown, Julia
700	1		_aBooth, Gillian A
700	1		_aVarghese, Abraham M
700	1		_aPocock, Christopher
773	0		_tBritish journal of haematology _gvol. 152 _gno. 5 _gp. 570-8
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2010.08317.x _zAvailable from publisher's website
999			_c20514996 _d20514996